生命科學分析市場規模、佔有率和成長分析：按組成部分、類型和地區 - 產業預測，2024-2031 年

2022年，全球生命科學分析市場規模將達到268億美元，預測期內（2024-2031年）複合年成長率為11.4%，從2023年的298.6億美元增加到2031年的701億美元。

由於醫療保健資料呈指數級成長以及對資料主導洞察的需求不斷成長，生命科學分析市場正在經歷快速成長。包括電子健康記錄、基因組資料和現實世界證據在內的各種資料來源的融合正在為分析應用創建豐富的生態系統。透過利用人工智慧和機器學習等先進技術，生命科學公司可以釋放寶貴的見解，以加速藥物發現、最佳化臨床試驗並改善患者治療結果。儘管資料隱私、整合和人才獲取方面的挑戰仍然存在，但在醫療保健產業對資料主導決策和創新的需求不斷成長的推動下，生命科學分析的整體市場前景仍然樂觀。

目錄

介紹

• 研究目的
• 定義
• 市場範圍

調查方法

• 資訊採購
• 次要/一級資訊來源
• 市場規模預測
• 市場假設與限制

執行摘要

• 市場概況展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 任務
• 波特的分析

主要市場考察

• 市場成功的關鍵因素
• 競爭程度
• 關鍵投資機會
• 市場魅力指數
• 生態系繪圖
• 技術分析
• 供應鏈分析
• 價值鏈分析
• 營運分析
• 專利分析
• 貿易分析
• 價格分析
• 使用案例分析
• Start-Ups分析
• 管道分析

生命科學分析市場：按類型

• 市場概況
• 概括
• 預測性的
• 規範的

生命科學分析市場：依組成部分

• 市場概況
• 軟體
• 服務

生命科學分析市場：依分佈

• 市場概況
• 本地交付模式
• 按需交付模式

生命科學分析市場：依應用分類

• 市場概況
• 研究與開發
  • 臨床試驗
  • 臨床前測試
• 銷售和行銷
• 藥物警戒
• 監理合規性
• 供應鏈最佳化

生命科學分析市場：依最終用戶分類

• 市場概況
• 製藥和生物技術公司
• 醫療設備公司
• 研究中心
• 第三方管理員

按地區分類的生命科學分析市場規模

• 市場概況
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲 (MEA)
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲地區

競爭格局

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市集活動
• 主要企業市場佔有率（2023年）

主要企業簡介

• ORACLE（US）
• IBM（US）
• SAS INSTITUTE INC.（US）
• ACCENTURE（Ireland）
• IQVIA INC.（US）
• COGNIZANT（US）
• WIPRO（India）
• ALLSCRIPTS HEALTHCARE, LLC（US）
• OPTUM, INC.（US）
• MICROSOFT（US）
• MAXISIT（US）
• EXLSERVICE HOLDINGS, INC.（US）
• CERNER CORPORATION（US）
• CITIUSTECH INC.（US）
• SAAMA TECHNOLOGIES, LLC（US）
• AXTRIA（US）
• CLARIVATE（UK）
• THOUGHTSPHERE（US）
• ALTERYX, INC.（US）
• SISENSE INC.（US）
• AMAZON WEB SERVICES, INC.（US）
• VEEVA SYSTEMS（US）

Global Life Science Analytics Market size was valued at USD 26.80 Billion in 2022 and is poised to grow from USD 29.86 Billion in 2023 to USD 70.10 Billion by 2031, at a CAGR of 11.4 % during the forecast period (2024-2031).

The life science analytics market is experiencing rapid growth fueled by the exponential increase in healthcare data and the growing need for data-driven insights. The convergence of various data sources, including electronic health records, genomic data, and real-world evidence, has created a rich ecosystem for analytics applications. By leveraging advanced technologies such as artificial intelligence and machine learning, life sciences organizations can extract valuable insights to accelerate drug discovery, optimize clinical trials, and improve patient outcomes. While challenges related to data privacy, integration, and talent acquisition persist, the overall market outlook for life science analytics remains positive, driven by the increasing demand for data-driven decision-making and innovation in the healthcare industry.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Life Science Analytics Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Life Science Analytics Market Segmental Analysis

The global life science analytics market is segmented on the basis of type, component, delivery, application, end-user and region. Based on type, the market is segmented into descriptive, predictive, and prescriptive. Based on component, the market is segmented into software, and services. In terms of delivery, the market is segmented into on-premise model, and on-demand model. By application, the market is segmented into research & development, preclinical trials, clinical trials, sales & marketing, regulatory compliance, supply chain optimization, pharmacovigilance. By end-user, the market is segmented into pharmaceutical & biotechnology companies, medical device companies, research centers, and third-party administrators. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Life Science Analytics Market

The growing utilization of real-world data (RWD) is revolutionizing the life sciences industry. By harnessing the power of electronic health records, wearables, and other data sources, organizations can gain valuable insights into patient populations, disease progression, and treatment effectiveness. RWD enables the development of more targeted therapies, accelerates drug development timelines, and supports evidence-based decision-making. As the volume and complexity of RWD continue to expand, advanced analytics and data management capabilities will be essential for unlocking its full potential.

Restraints in the Global Life Science Analytics Market

Data privacy and security are critical challenges in the life science analytics market. The handling of sensitive patient data requires stringent measures to protect information from unauthorized access, breaches, and misuse. Compliance with regulations like GDPR and HIPAA is essential to maintain patient trust and avoid legal repercussions. Organizations must invest in robust security infrastructure, implement data encryption and access controls, and adhere to strict data governance practices. Additionally, ensuring data quality and integrity is crucial for deriving accurate and reliable insights. By addressing these challenges, life science organizations can build trust with patients and stakeholders while maximizing the value of their data assets.

Market Trends of the Global Life Science Analytics Market

The demand for real-time analytics is rapidly increasing as organizations seek to gain a competitive edge and make data-driven decisions at the speed of business. By processing and analyzing data as it is generated, businesses can identify trends, patterns, and anomalies instantaneously, enabling timely interventions and optimized operations. This shift towards real-time insights is being driven by factors such as the increasing volume and velocity of data, the rise of IoT devices, and the need for rapid response to market changes. As technology continues to advance, real-time analytics is expected to become a critical capability for organizations across industries.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors of The Market
• Degree Of Competition
• Top Investment Pockets
• Market Attractive Index
• Ecosystem Mapping
• Technology Analysis
• Supply Chain Analysis
• Value Chain Analysis
• Operational Analysis
• Patent Analysis
• Trade Analysis
• Pricing Analysis
• Use Case Analysis
• Startup Analysis
• Pipeline Analysis

Life Science Analytics Market by Type

• Market Overview
• Descriptive
• Predictive
• Prescriptive

Life Science Analytics Market by Component

• Market Overview
• Software
• Services

Life Science Analytics Market by Delivery

• Market Overview
• On-Premise Delivery Model
• On-Demand Delivery Model

Life Science Analytics Market by Application

• Market Overview
• Research & Development
  • Clinical Trials
  • Preclinical Trials
• Sales & Marketing
• Pharmacovigilance
• Regulatory Compliance
• Supply Chain Optimization

Life Science Analytics Market by End-User

• Market Overview
• Pharmaceutical & Biotechnology Companies
• Medical Device Companies
• Research Centers
• Third-party Administrators

Life Science Analytics Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• ORACLE (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IBM (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SAS INSTITUTE INC. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ACCENTURE (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IQVIA INC. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• COGNIZANT (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WIPRO (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ALLSCRIPTS HEALTHCARE, LLC (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OPTUM, INC. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MICROSOFT (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MAXISIT (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EXLSERVICE HOLDINGS, INC. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CERNER CORPORATION (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CITIUSTECH INC. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SAAMA TECHNOLOGIES, LLC (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AXTRIA (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CLARIVATE (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• THOUGHTSPHERE (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ALTERYX, INC. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SISENSE INC. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AMAZON WEB SERVICES, INC. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VEEVA SYSTEMS (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments